These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11521528

  • 1. [Chronic aluminum intoxication in patients with terminal kidney failure on programmed hemodialysis (literature review)].
    Milovanova LIu, Nikolaev AIu, Barashkov GK.
    Ter Arkh; 2001; 73(6):67-9. PubMed ID: 11521528
    [No Abstract] [Full Text] [Related]

  • 2. [Unusual course of renal osteopathy with Paget's disease and aluminum deposits].
    Ringe JD, Delling G.
    Dtsch Med Wochenschr; 1985 Mar 15; 110(11):411-5. PubMed ID: 3979272
    [Abstract] [Full Text] [Related]

  • 3. Management of bone disease in the dialysis patient.
    Crooks PW, Coburn JW.
    Blood Purif; 1985 Mar 15; 3(1-3):27-41. PubMed ID: 3913448
    [Abstract] [Full Text] [Related]

  • 4. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ.
    ANNA J; 1985 Jun 15; 12(3):189-91. PubMed ID: 3848318
    [No Abstract] [Full Text] [Related]

  • 5. Recognition and management of aluminum intoxication in children.
    Tsuru N, Williams JL, Chan JC.
    Int J Pediatr Nephrol; 1987 Jun 15; 8(3):177-86. PubMed ID: 3323095
    [Abstract] [Full Text] [Related]

  • 6. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F, Giachino G, Bossi P, Gilli G, Corrao G, Scursatone E, Jeantet A, Bossi R, Coppo R, Piccoli G, Vercellone A.
    Minerva Nefrol; 1980 Jun 15; 27(4):635-44. PubMed ID: 7254691
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The role of aluminum in the human body].
    Strzałkowska D.
    Postepy Hig Med Dosw; 1991 Jun 15; 45(3-4):257-79. PubMed ID: 1946095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
    Nebeker HG, Andress DL, Milliner DS, Ott SM, Alfrey AC, Slatopolsky EA, Sherrard DJ, Coburn JW.
    Kidney Int Suppl; 1986 Feb 15; 18():S96-9. PubMed ID: 3458006
    [No Abstract] [Full Text] [Related]

  • 13. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J, Brunfaut C.
    J Radiol Electrol Med Nucl; 1974 Jan 15; 55(1):35-9. PubMed ID: 4831994
    [No Abstract] [Full Text] [Related]

  • 14. [Osteodystrophy in patients with chronic kidney insufficiency].
    Ermolenko VM, Nikiforsva NV.
    Urol Nefrol (Mosk); 1970 Jan 15; 35(5):57-63. PubMed ID: 4929738
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S, Oprisiu R, Benamar L, Said S, Tataru Albu A, Arsenescu I, el Esper N, Morinière P, Fournier A.
    Nephrologie; 2000 Jan 15; 21(8):413-24. PubMed ID: 11213385
    [Abstract] [Full Text] [Related]

  • 20. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW.
    Kidney Int Suppl; 1993 Feb 15; 40():S92-100. PubMed ID: 8445845
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.